Gergen Mark J
Executive Chairman at PSTX; Executive VP, COO at Mirati Therapeutics, Inc.; SVP, Corporate Development at AMYLIN PHARMACEUTICALS INC
- Sold, on record
- $1.4M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Dec 10, 2024
- Form 144 notices
- 1
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- PSTXPoseida Therapeutics, Inc.Executive Chairman
- Mirati Therapeutics, Inc.Executive VP, COO
- AMYLIN PHARMACEUTICALS INCSVP, Corporate Development
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- PSTX60,000 shares
- AMYLIN PHARMACEUTICALS INC17,864 shares
- Mirati Therapeutics, Inc.10,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AMYLIN PHARMACEUTICALS INCPlan not statedOct 3, 2007 2007
Sold 500 shares at $50.00 ($25k)
Gergen Mark J, Sr VP, Corporate Development
Sold 14.5% of holdings ($172k position)2,937 shares left1x usual sizeFiling
- 2 Form 4 sale AMYLIN PHARMACEUTICALS INCPlan not statedNov 1, 2007 +29 days
Sold 500 shares at $44.00 ($22k)
Gergen Mark J, Sr VP, Corporate Development
Sold 14.5% of holdings ($151k position)2,937 shares left1x usual sizeFiling
- 3 Form 4 sale AMYLIN PHARMACEUTICALS INCPlan not statedFeb 23, 2012 +1575 days
Sold 7,518 shares at $17.03 ($128k)
Gergen Mark J, SVP, Corporate Development
Sold 12.1% of holdings ($1.1M position)54,826 shares leftFirst sale on recordFiling
- 4 Form 4 sale AMYLIN PHARMACEUTICALS INCPlan not statedMar 1, 2012 +7 days
Sold 1,846 shares at $17.11 ($32k)
Gergen Mark J, SVP, Corporate Development
Sold 3.3% of holdings ($952k position)53,814 shares leftFiling
- 5 Form 4 sale Mirati Therapeutics, Inc.UnusualJan 15, 2016 +1415 days
Sold 10,000 shares at $25.92 ($259k)
Gergen Mark J, Executive VP, COO
Sold 63.5% of holdings ($408k position)5,748 shares leftFirst sale on recordFiling
- 6 Form 144 notice PSTXNoticeNov 26, 2024 +3238 days
Filed to sell 120,000 shares ($343k)
Gergen Mark J, Director, Officer
10b5-1 planFirst sale on recordFiling
- 7 Form 4 sale PSTXRoutineNov 26, 2024 same day
Sold 30,000 shares at $9.27 ($278k)
Gergen Mark J, Executive Chairman
10b5-1 planSold 4.4% of holdings ($6.3M position)651,291 shares leftFirst sale on recordFollows a Form 144Filing
- 8 Form 4 sale PSTXRoutineDec 10, 2024 +14 days
Sold 30,000 shares at $9.46 ($284k)
Gergen Mark J, Executive Chairman
10b5-1 planSold 4.4% of holdings ($6.4M position)651,291 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | Dec 11, 2024 | PSTX | Executive Chairman | Form 4 sale | 30,000 | $284k | 4.4% | Routine | SEC |
| Nov 26, 2024 | Nov 27, 2024 | PSTX | Executive Chairman | Form 4 sale | 30,000 | $278k | 4.4% | Routine | SEC |
| Nov 26, 2024 | Nov 26, 2024 | PSTX | Director, Officer | Form 144 notice | 120,000 | $343k | Notice | SEC | |
| Jan 15, 2016 | Jan 19, 2016 | Mirati Therapeutics, Inc. | Executive VP, COO | Form 4 sale | 10,000 | $259k | 63.5% | Unusual | SEC |
| Mar 1, 2012 | Mar 2, 2012 | AMYLIN PHARMACEUTICALS INC | SVP, Corporate Development | Form 4 sale | 1,846 | $32k | 3.3% | Plan not stated | SEC |
| Feb 23, 2012 | Feb 24, 2012 | AMYLIN PHARMACEUTICALS INC | SVP, Corporate Development | Form 4 sale | 7,518 | $128k | 12.1% | Plan not stated | SEC |
| Nov 1, 2007 | Nov 2, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $22k | 14.5% | Plan not stated | SEC |
| Oct 3, 2007 | Oct 4, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $25k | 14.5% | Plan not stated | SEC |
| Oct 1, 2007 | Oct 2, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $25k | 14.5% | Plan not stated | SEC |
| Sep 4, 2007 | Sep 6, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 1,000 | $50k | 25.4% | Unusual | SEC |
| Aug 7, 2007 | Aug 8, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $25k | 14.5% | Plan not stated | SEC |
| Aug 1, 2007 | Aug 2, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $23k | 14.5% | Plan not stated | SEC |
| Jul 24, 2007 | Jul 25, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $23k | 14.5% | Plan not stated | SEC |
| Jul 2, 2007 | Jul 3, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $21k | 14.5% | Plan not stated | SEC |
| Jun 1, 2007 | Jun 4, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 1,000 | $46k | 25.4% | Unusual | SEC |
| May 21, 2007 | May 23, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $23k | 14.5% | Plan not stated | SEC |
| May 1, 2007 | May 2, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $21k | 14.5% | Plan not stated | SEC |
| Apr 2, 2007 | Apr 3, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $19k | 14.5% | Plan not stated | SEC |
| Mar 1, 2007 | Mar 2, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $19k | 14.5% | Plan not stated | SEC |
| Feb 1, 2007 | Feb 2, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $19k | 16.1% | Plan not stated | SEC |
| Jan 3, 2007 | Jan 4, 2007 | AMYLIN PHARMACEUTICALS INC | Sr VP, Corporate Development | Form 4 sale | 500 | $18k | 18.6% | Plan not stated | SEC |